Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-24 @ 11:02 PM
NCT ID:
NCT01942369
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with DIE and having received surgery treatment within one month before inclusion
* Premenopausal women aged \>=18 years old.
* Written ICF has been obtained prior to any study-related procedures
* Patient for whom the treating physician already made the decision to treat by Diphereline.
* Patient should be mentally and physically able to express her symptom complaints and answer questions.
Exclusion Criteria:
* Pregnancy or lactation.
* Patients currently on treatment or who have been on therapy with a GnRHa in the last 6 months.
* Premenopausal women who may reach menopause within the 3 years post randomisation.
* Hypersensitivity to Triptorelin or one of the excipients of Triptorelin 3.75mg
* Treatment with another research drug over the last 3 months before the study
* Potentially unreliable patients, and those judged by the investigator to be unsuitable for the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01942369
Study Brief:
Protocol Section:
NCT01942369